Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Embecta (EMBC) Deferred Taxes (2021 - 2026)

Embecta recorded quarterly Deferred Taxes of $6.4 million in Q1 2026, up 88.24% quarter-over-quarter from $3.4 million in Q4 2025, and up 93.94% year-over-year from $3.3 million in Q1 2025.

Embecta's Deferred Taxes history runs 6 years deep, the most recent figure standing at $6.4 million for Q1 2026.

  • In Q1 2026, Deferred Taxes rose 93.94% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $21.8 million (up 185.83% YoY), while the FY2025 annual figure was $17.6 million, up 124.93% from the prior year.
  • Deferred Taxes came in at $6.4 million for Q1 2026 at Embecta, up from $3.4 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $12.1 million in Q3 2023 to a low of -$27.7 million in Q3 2024.
  • A 5-year average of -$3.5 million and a median of $1.2 million in 2022 frame the typical range for Deferred Taxes.
  • Across the five-year window, Deferred Taxes tumbled 11200.0% in 2024 and soared 290.91% in 2025, its largest moves.
  • Embecta's Deferred Taxes stood at $1.4 million in 2022, then plunged by 1314.29% to -$17.0 million in 2023, then surged by 113.53% to $2.3 million in 2024, then soared by 47.83% to $3.4 million in 2025, then soared by 88.24% to $6.4 million in 2026.
  • According to Business Quant data, Deferred Taxes over the past three periods registered $6.4 million, $3.4 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -339.30 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -73.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -41.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 43.60 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 40.64 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 29.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -4.57 Mn
10 Embecta 197.17 Mn 3.77 Mn 127.80 Mn 6.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.40 Mn
Dec 31, 2025 3.40 Mn
Sep 30, 2025 5.70 Mn
Jun 30, 2025 6.30 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 -27.70 Mn
Jun 30, 2024 -3.30 Mn
Mar 31, 2024 -22.60 Mn
Dec 31, 2023 -17.00 Mn
Sep 30, 2023 12.10 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 -200,000.00
Dec 31, 2022 1.40 Mn
Sep 30, 2022 -26.90 Mn
Jun 30, 2022 400,000.00
Sep 30, 2021 -2.80 Mn